Topper James N is a corporate insider with SEC Form 4 filings on record. No transactions have been reported in the past 12 months. Historical filings, if any, are searchable below.

Topper James N

Director

Latest Insider Transactions

Showing 10 of 14 transactions (past 365 days)

NAMS
Director
Purchase
$15.6K
660 shares @ $23.70
Filed 2025-09-17Trade 2025-09-15
Newamsterdam Pharma Co N.V.
NAMS
Director
Purchase
$31.5K
1,260 shares @ $24.99
Filed 2025-09-10Trade 2025-09-08
Newamsterdam Pharma Co N.V.
NAMS
Director
Purchase
$11.3K
471 shares @ $23.98
Filed 2025-08-13Trade 2025-08-11
Newamsterdam Pharma Co N.V.
NAMS
Director
Purchase
$23K
1,260 shares @ $18.26
Filed 2025-06-26Trade 2025-06-25
Newamsterdam Pharma Co N.V.
NAMS
Director
Purchase
$46.5K
2,520 shares @ $18.43
Filed 2025-06-26Trade 2025-06-24
Newamsterdam Pharma Co N.V.
NAMS
Director
Purchase
$167.4K
8,584 shares @ $19.50
Filed 2025-06-18Trade 2025-06-16
Newamsterdam Pharma Co N.V.
PHAT
Director
Award
$0
17,500 shares @ $0.00
Filed 2025-06-05Trade 2025-06-03
Phathom Pharmaceuticals, Inc.
PHAT
Director
Award
$0
10,500 shares @ $0.00
Filed 2025-06-05Trade 2025-06-03
Phathom Pharmaceuticals, Inc.
PHAT
Director
Purchase
$14.6K
3,780 shares @ $3.87
Filed 2025-05-23Trade 2025-05-21
Phathom Pharmaceuticals, Inc.
PHAT
Director
Purchase
$20.9K
6,300 shares @ $3.32
Filed 2025-05-15Trade 2025-05-14
Phathom Pharmaceuticals, Inc.

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.